Breaking News
February 23, 2019 - Acupuncture Could Help Ease Menopausal Symptoms
February 23, 2019 - Researchers use AI to detect early signs of Alzheimer’s
February 23, 2019 - On recovery, vulnerability and ritual: An exhibit in white | News Center
February 23, 2019 - Memory Stored in Unexpected Region of the Brain
February 23, 2019 - Several health experts worldwide gather at EUDONORGAN event
February 23, 2019 - Discovery of potent compound in native California shrub may lead to treatment for Alzheimer’s
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Morning walks could be better than drugs at lowering blood pressure
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
KNAUER high-pressure dosing pumps contribute to the success of Grillo’s new MSA synthesis

KNAUER high-pressure dosing pumps contribute to the success of Grillo’s new MSA synthesis

image_pdfDownload PDFimage_print

The Berlin-based manufacturer of laboratory measuring instruments KNAUER Wissenschaftliche Geräte GmbH reported today that its high-pressure metering pumps played an important role in the development of the groundbreaking new manufacturing process of methanesulfonic acid (MSA) directly from methane and sulfur trioxide, which was successfully realized by researchers from Duisburg’s Grillo-Werke AG.

KNAUER dosing pumps. Credit: KNAUER

Currently methanesulfonic acid is already produced on an industrial scale. Its strongly acidic but non-oxidizing properties make it an interesting catalyst for many reactions in organic chemistry, especially in polymerizations.

Methanesulfonic acid is also used in electroplating and increasingly also in industrial cleaners, where it is used as a substitute for phosphoric, hydrochloric or sulfuric acid, because it is less harmful to the environment at comparable or greater efficacy than the mineral acids used previously.

The preparation of methanesulfonic acid is currently relatively expensive, because of multi-stage processes, which are partly dependent on toxic intermediates such as dimethyl disulfide.

The direct reaction of methane with sulfur trioxide would be the most obvious solution. Researchers worldwide have long been experimenting with the direct activation of methane.

As early as in the 1950s, a US patent was filed using sulfur trioxide, however, the achieved yields of methanesulfonic acid were low and the number of unwanted by-products high.

The Grillo researchers took a different approach than most other researchers. They relied on relatively mild temperatures below 100 degrees Celsius and pressures around 50 bar only.

The cunning in their process is an activator molecule that triggers sulfonation and can easily be re-synthesized from MSA and sulfuric acid in a secondary process. By the way, sulfuric acid serves as a solvent in the process.

A tricky part of the new MSA synthesis is the precise metering of sulfur trioxide (SO3) into the chemical reactor. Sulfur trioxide is only liquid in a narrow temperature range between 32°C and 44°C, reacts violently when in contact with water and chars most plastics very quickly. This means that it is very difficult to handle.

In search of suitable pumps for this task, we had already received a few cancellations from suppliers before turning to KNAUER. KNAUER also could not offer us a model off the shelf, but they were the only manufacturer to embark on a little development trip,”

said Dr. Timo Ott, Head of Product and Process Development for the chemistry branch at Grillo.

KNAUER high-pressure dosing pumps are based on HPLC technology and inherently provide high chemical resistance, excellent flow rate precision, and low pulsation.

However, pumping liquid sulfur trioxide required customization, especially with regard to plastic parts in the flow path. Another important prerequisite for the success was the powerful pump head heating offered by KNAUER in order to keep sulfur trioxide fluid even at low flow rates or necessary stops.

It is part of our company philosophy that we find beneficial solutions for our customers and together with them. We are particularly pleased that we were able to make our contribution to the success of Grillo’s MSA synthesis, which is, in my opinion, a research project of global importance,”

Dr. Christian Benkhäuser, Head of Hardware Development at KNAUER.

The special feature of the methanesulfonic acid production process developed by the Grillo researchers is that it works much more efficiently than previous processes and makes methane usable as a carbon source for sulfonation.

Certainly, with this process methane is becoming more important as a raw material. Wasting methane through flaring will hopefully become less common. Using biogas as a source of methane, the process can do without a fossil carbon source.

A recently published comparative life cycle assessment (LCA) study from the University of Zurich concludes that the new process has a three times smaller environmental impact than previous methods. Greenhouse gas emissions are 85% lower.

When the new manufacturing process for methanesulfonic acid will be introduced on an industrial scale, the environment will benefit of it,”

Dr. Biertümpel is Head of R & D in the Chemistry Branch of Grillo-Werke AG and the company’s Sustinability Officer

He is Head of R & D in the Chemistry Branch of Grillo-Werke AG and the company’s Sustainability Officer.

Something else is already clear today: It is worthwhile, as Grillo has done here, to leave the beaten path, it is also worthwhile, like KNAUER, not to say hastily “we can’t deliver that” and it is fun working together to develop new solutions.

Source:

https://www.knauer.net/en/usually-in-the-background-today-they-are-in-the-spotlight-knauer-high-pressure-dosing-pumps/n24318

Tagged with:

About author

Related Articles